Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MM didn’t bring this below $4 but not for lack of trying. Long weekend of more speculation and waiting. Let’s hope we get some movement on the news front especially with the start of Longhaulers trial which should be filled in 10 days. Still able to buy in at low of day. So much manipulation right now with no concrete news. Just have to hold tight and expect the best. Overall markets are weakening as strength in recovery picks up most likely due to the pace of vaccines. States pushing full openings and no masks which judging by past there will be a rise in cases and hospitalization. How convenient yet inconvenient. Week 3 is up now. Let’s see if FDA stalls us longer or NPs timeframe for once is accurate. Something is brewing in the hopper. Must be almost time for that 5 o clock brewskie.
On that note we have put that $3.80 out there not knowing for certain it would be hit, but there is slight possibility. We do see the range of $4.25. -$4.50. Tight range until the holy grail PR comes out. Odds favor a positive one, but with FDA who knows what will happen. Definitely am getting lots of feedback that a few secondary endpoints were hit with Stat Sig and discussions are about the treatment plan regarding those endpoints. Not written in stone but strong lean that wayIMO. If we get the full enchilada all the better. Revenue is revenue so an EUA for any endpoint however limited it may be still brings in money. Top that off with the real money maker Longhaulers, that is where the cream will rise t the top many billions in recurring sales
C-20 everyone has their own strategy when it comes to making money. Daytraders especially want in and out. They don’t care where stock will be in 5 days from now or a year. Shirts are different. More money to invest to cause a drop. Ones that get hurt are newbies
Not yet. Long trading day although I do see a bounce toward end of day. Daytraders and shorts made their money already on run up and now as usual for the pullback
Days far from over. Don’t get ahead of yourself. We have seen this headfake before.
Loading up when this hits $3.80 early tomorrow
6pm eastern was correct after all
Friday
6pm
Yes you are correct. Many typos with spellcheck on new phones interprets what you intend to say and without proofreading mistakes happen. Shorts make the game even. Naked shorts make the game illegal. It is easy to be a shirt with all of the FUD created by blown timelines and fantastical statements that are debunked time and time again. Yet all CYDy needs to do is be right once in their prediction and a little cooperation from the powers that be and we will be on our way.
Misiu very true. There are many things that we don’t know and some we do. Transparency is definitely not something that is valued either by FDA or Cytodyn. Every message is fumbled which leads to two sides of the coin and the truth obscured. We are all conspiring and guessing what is going on behind the scenes. Longs on the positive side of the coin and shirts on the negative. But what really is the truth? Are we being slow rolled and played like a fiddle by the FDA? Or is NP storytelling to bide time and hoping for approvals? Is two -three weeks the actual timeframe? What happens when it goes beyond that which is quite possible. Not everyone can boast buying in sub $1 and the longer this goes on without an announcement of substance, the worse the financial situation becomes. I don’t think we can survive w/o major dilution. Also if we get the runaround in CD-12 is it even worth it to continue pursuing Longhaulers? Too many cooks in the kitchen spoil the broth. If it’s an ng on Cd-12 I think that no offers will come from any BP until we get some kind of approval.
The next back breaker will be closing below $4 which is truly a possibility. There are just too few institutional investors to make up for the shirts dropping price. Hedges and MM are in control of where this price heads for now. As many retail investors that want to back up the truck and load up on cheap shares, there is just not much firepower to make a dent. It’s the trickle down effect. Naturally patience weans and frustration builds with each passing day. Optimistic outlooks break down.
Seeing continued hits with no news below !4 possibly $3.80 before bounce back settling $4.25 and $4.50
Here is big problem with having all these indications in the pipeline. Having a great drug but horrible people roger it across the finish line is a big problem. It’s like the gang that can’t shoot straight. First it is the BLA for HIV? Do we have any factual clues as to what really happened with that? To date the answer is no. Then we go to CD-10 which was fumbled from PE and protocols to announcements in piecemeal which was dragged out and caused major problems. Now the almost exact PR was used for CD-12 our best hope and we are awaiting what the FDA has to say. Add in all of the crazy PRs that get announced and never come to fruition and that’s where we have the biggest problem. Creditable and trustworthiness from our leader. It’s not so much just about being patient, but the spin that comes along with it is questionable at least. NP comes off eager and genuine but at times he is a used car salesman at best and hides behind the fact that we are a small company who has to get shady financing to do deals which puts much shade on CYDY. It feels like we just aren’t taken seriously by the powers that be. So without advancing anything to an approval to date, what difference does it make to have 60 indications which have to be studied and trialed when we can’t get anything over the finish line now? With no revenue all these other possible indications are just pipe dreams.
Let them drop it like it’s hot, I have my buy order in really big for.01c as they are predicting the shirts I will buy my 5million shares
True about s/C but the perception of time sucks. Anticipation. I’m used to it big on the glass bottle of Heinz ketchup. Nowadays nobody waits just squeeze plastic sort of like what’s coming to the shirts.
Just really sucks being left out of the game. Tough being a small independent company when you know that we are the best and watching everyone get a chance to play knowing they stink. However, investigative minds want to know why we have been pushed aside and left for dead. Here is one thing I know. The announcement will come after hours. FDA is a government agency that likes to be seen and heard so a nightly news time would be appropuand usually they make Major Announcement on Thursdays. I am hearing chirping and not from the birds, that FDA and CDC are highly worried about variants and fourth wave. The silence before the storm is here and that is why there is so much of a rush to push vaccines to try and reach herd immunity by May. They are very fearful that the current vaccines will not be able to work on the evolving mutations and variants and now with restrictions on gatherings and masks being rescinded, it is only a matter of weeks before we really ramp up in cases
450/507
There isn’t that many more moves on the chess board. We have pretty much mastered our moves and are awaiting validation of trials during a well played game. Top moves left are to overthrow the lousy SOC and become the reigning new SOC champion in a clean sweep of CD-10, CD-12& Longhaulers. I’m not into chess but my analogy would be the equivalent to battleship. We know exactly what target to hit and are ready to strike. I have a very strong rating on imminent approval in a short time and uplist to follow. The prediction center has this as an incredible buy.
Meanwhile back at the ranch, Mahoob is definitely progressing with the BLA for HIV. Don’t believe for one second that there has not been substantial progress taking place as well as for Cancer. Right now we will only hear about Covid. That does not mean that they have stopped in the work that needs to be completed on the BLA. One shot is all it takes to move the needle. We have previously put out a number that should be hit soon. GLTA
Monoclonal antibodies will be all the rage very soon. With variants and mutations now becoming the leading factor in new cases, it’s just a matter of time the inevitable writing on the wall. Vaccines will become less potent and many new formulations will be needed to render them effective. Many of the monoclonal antibodies that deal with the spike protein will become useless do to the mutations. Virologix MOA as we quite well know does not deal with the spike protein. Mutations and variants will not affect how it works. Therefore in light of all negative comments some will be proven very wrong in their assessment and beliefs that it is a saline shot. FDA is well aware of this and Janet Woodcock has known about Virologix for a while now. If BP has no influence on the decision and delay, it is just a matter of time before we are given an EUA. The need for vaccines is there to reduce hospital admissions. Cases of variants are rising in 27 states and with 2000 deaths a day from Covid, apparently there will be a major need for CYDY to fill the coid
Nice. When we see total shares traded around 800-1.2 million shares, the juice will be totally squeezed. No long is selling anything only accumulating on small drips down. Two weeks will be over Friday and next week the miracle drug should be a household name. Just throw in Longhaulers media attention and let’s just say jack n the beanstalk will be the green shoots we will see. Best Of Luck
C-20 I will not give that info out. I will say that it appears that we are due for rise in share price but with no news just bumping along. With each rise there seems to be shirts that take it down to make some cash whether it’s at start of day or mid day but usually not at end of day. There is tons of money and eyes on this stock right now. C.V.s are looking for the next big thing for their clients but will not show their band until we get closer and get some clarity of the situation. Hang tight like you have been and believe in the science. It will set us free.
Also I am getting rid of all my saline solutions in my medicine cabinet and will order Virologix. I prefer a name brand of saline.
Against better judgement I’m trusting the shorts and put a large buy order in for .01 cents. They could be wrong of course but at that price I feel this will be a bargain
But we need reasoning. So many of us want answers that just never seem to come. It’s why share price drops because of nothing concrete. Everything with NP is a riddle. Wouldn’t it be nice to know what the heck is going on for once. So vague that we are always conspiring to figure out the true meaning behind these PRs? I am baffled ! I am patient and long, but just for once give it to me straight instead of piecemeal choppiness. I already said my piece that we will get EUA on secondary endpoints slam dunk. The rest as far as primary go, I think that is reason for delay, that they are still gaining data from OLE and EINDs because of all the earlier screw ups and cronyism. Now they want to be sure but what would seem to go in our favor is the fact that their are many interests at the table. I think we have a great shot with longhaulers too but that will depend on CD-12 results.
Herein lies the problem. There are nuggets and indications that safe to say a relatively thoughtful analysis of where we are in the process would lead us to believe that things look stellar. Based on EINDs, papers written, testimonials, MOA etc that looking at unblinding and raw data would lead us to believe that an approval was imminent. Add in Medicaid code, also what we presume as no bad news 4 days after last weeks PR would mean positive results and EUA expected. But alas, here we are waiting on the next PR and who knows with NPs track record, it gives rise to shirts conspiracy theories. I am a believer in science and Leronlimab as many of us are. I think the wild card is management and especially NP with his many wild stories that make him out to be the boy who cried wolf too many times. Now of course this scenario changes somewhat with if truthful, FDA requesting the raw data as well as discussions with UK and Canada. But we have been told many half truths before that the credibility of NP is subject at best to mishandling of information and PRs before. Truth be known in a matter of time. Are shirts wrong this time? Let’s hope so, but if NP once again distorts shareholders, there is going to be one hell of a price to pay.
Does anyone know if the CEO was ever convicted of a crime 30 years ago? Or enriched himself with shares and was subsequently found guilty and had to return shares? Can anyone tell me if the unblinded data that was sent to FDA is bad and CYDY is burying the data? I’m sure someone knows something and can fill me in about this saline shot? Anyone care to try to convince me that this drug is a loser for the 1000th time? Guess what it ain’t working. Put your ears to the train tracks people. There are big rumblings going on in our circle. The blowing of the train whistle is moments away. The smoke is billowing from the stack. It’s about to get loud 72
Just such a world of knowledge. Fascinating
You should be very proud
Have to say the posts today more light than usual. I really feel that there is no need to hear the noise being put out there. Must be kinda funny knowing how much we believe that Cydy is a success that our kids know it. Talk about knowledge and generational wealth to pass down.
So when do you think approval will come and the world be able to be saved by the so called “ Saline Shot” that longs recognize as Virologix the proper name.The Irish in me thinks by St. Patrick’s Day
I don’t think they need an excuse. They are gonna do what they do day in and day out. It’s a vicious cycle of small gains and bigger losses. Let’s hope an approval will change that ratio. I do not think that anyone knows all that needs to be known. It’s all speculation at this time. Our drug is way different in MOA and being guided by EINDs and results, papers written and many discussions, there is positively endpoints that were hit. Question is do we have Stat Sig in Primary? DSMC recommendation to 75% at 42 days is telling, but add the latest puzzle piece with FDA at 60 and you can see why we may have once again muddied the field by going completed trial at 28 day. This will not have any bearing on secondary endpoints though. We still did what FDA requested which was to give raw data after unblinding so in that respect, maybe FDA, UK & Canada can come to a consensus on the endpoints and dosage/ labeling& distribution.
Hard to stay involved yet drown out all the outside noise. Things happen quite slowly even during a pandemic. Reminds me of how government works. So much sausage making and procedure to get to an answer. Snails pace.
What makes this difficult is not knowing squat. We are here trying to put our own spin on what we believe might be the outcome. 500 people 500 opinions. This gives NP cover for now to remain silent and leaves the decision up to FDA. So here we start the Longhaulers trial which hopefully will be the answer to chronic Covid. All the while we wait for a decision on approval and EUA for S/C. How effective will next trial be if we get denied for S/C because of 28 day PE ? Will we be allowed to use 42&60 day thresholds or has that boat sailed? Let’s hope 2/3 weeks is really the time frame. We need news and promising at that.
I think trust and lack of it is very real here. We know the boy NP has cried wolf so many times, you don’t know what to believe. Granted with a small bio given the choice to take the DSMC recommendation to do interim @75% and 42 day mortality or going with completed trial, we know time and money probably had a major impact on the decision. Now knowing FDA has pushed it out further to 60 days doesn’t really bode well if we have to go by 28 day PE. Stat Sig on shorter time frame could be achievable but as has been posted it depends on the makeup of enrollment. Were there more severe than critical patients enrolled? And if so by how many? Mortality in severe 15%-20% as compared to critical 30%-35%. So we unblinded and gave raw data to FDA and UK and Canada. In two or three weeks we will have the answer. Still sticking with a better probability of hitting a few secondary endpoints that will get us EUA. The discussions are needed to get on the same page for dosage and usage in those secondary endpoints.
Gonna put down pencil for a while. Seems very eerie the charting almost is as bad as stop loss orders, being used for nefarious reasons. Maybe coincidence but too close for comfort. Feeling as if it’s tipping shirts off. May be 100% wrong but why give any insights to help them out. Here is just some helpful hints to some newbies or weak hands. No stop loss orders period. Buy on the dips. Know what you own. Very good reads out there to start and many smart people with good links on this board. Hold on for the ride if your life. Best of luck to CYDY and longs who have kept up the faith and passion to see this through to the finish
Don’t know if this has been answered but because we went with full trial results does that lock us into PE at 28 day mortality ? Does the DSMC recommendation at 293 75% at 42 day mortality not matter because we filled trial and said we would go with completed enrolled trial PE.? These endpoints that have changed recently with DSMC recommendation as well as updated FDA expanding trials out to 60 days will hurt our results if we can’t use them. Trials that have not been completed will gain an advantage with the loosened timeframes.
Tomorrow we get word that J&J vaccine will get approval. Seems that all the noise is about vaccines and herd immunity at this time, but new variants are popping up every day and there is big fear of a 4th wave developing. Markets are shaky right now and we seem to be the go to for shorts, never satisfied with our losses and their gains. Until results are released, it is like a shooting gallery on the OTC bio market. Longs know what we have and will hold but any new blood seems ripe for the pickings. There is not enough buying to withstand the attacks right now. Wednesday run up was expected but today shirts let stock run up early and then played their cards not once but twice. Opened higher with resistance at $5 before finally getting through to $5.15 then first wave of shirt action came in bringing it down .70c pretty fast to $4.45. Not sure how we collapsed as we had $4.50 perfect. It setup and it ran slightly up to around $4.63 before round two of shirts may have scared those who bought in at $4.50-$4.63. GSK results have no comparison to our ongoing discussions with the big 3 but the narrative played out that maybe we will be given same type of results. Any doubts will be answered tomorrow with no PR for failure. Heading into the weekend looks like another battle brewing tomorrow as fear and FUD will play into shirts hoping to bring price down below $4. which for all intents and purposes could happen as resistance will be at $4 then much lower from there before retracing back to above $4. OTC is like the Wild West and with big market sell off today especially in bio there could be some more pain in the offing tomorrow. We are in it to win it. Long and hodl.
First of all I want to apologize. We missed it today. Looked real good for a while at the $4.50 mark but a second wave hit not just CYDY but the entire market was in a sell off. Good majority of Covid plays down. Top it off with the GSK news, that added a little downward pressure. Today was in gambling called a bad beat. Don’t get discouraged as this is the way it is in the wild Wild West of OTC. It seems like a puppet the strings get pulled by shirts and MM as CYDY becomes the good ole standby to short. But big difference is we will get the last laugh very soon. Who knows maybe even a surprise PR for an uplist. Enough to put the fear of ... into the shirts. Misiu great explanation in Cancer with Pestell